125 related articles for article (PubMed ID: 2513429)
1. Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart.
Ito T; Toki Y; Hieda N; Okumura K; Hashimoto H; Ogawa K; Satake T
Jpn Circ J; 1989 Sep; 53(9):1115-21. PubMed ID: 2513429
[TBL] [Abstract][Full Text] [Related]
2. The effects of lipoxygenase inhibitor and peptidoleukotriene antagonist on myocardial injury in a canine coronary occlusion-reperfusion model.
Toki Y; Hieda N; Torii T; Hashimoto H; Ito T; Ogawa K; Satake T
Prostaglandins; 1988 Apr; 35(4):555-71. PubMed ID: 3150113
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction.
Torii T; Toki Y; Hieda N; Ito Y; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T
Heart Vessels; 1988; 4(2):104-11. PubMed ID: 3253270
[TBL] [Abstract][Full Text] [Related]
4. Myocardial salvage by a novel thromboxane A2 synthetase inhibitor in a canine coronary occlusion-reperfusion model.
Toki Y; Hieda N; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T
Arzneimittelforschung; 1988 Feb; 38(2):224-7. PubMed ID: 3370068
[TBL] [Abstract][Full Text] [Related]
5. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist.
Nichols WW; Mehta J; Wargovich TJ; Franzini D; Lawson D
Angiology; 1989 Mar; 40(3):209-21. PubMed ID: 2537051
[TBL] [Abstract][Full Text] [Related]
6. Reduction of infarct size and infiltration of polymorphonuclear leukocytes by a thromboxane synthetase inhibitor. Studies in a rabbit ischemic heart model.
Ito T; Asai F; Ushiyama S; Matsuda K; Oshima T
Arzneimittelforschung; 1990 Jan; 40(1):23-7. PubMed ID: 1692704
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of neutrophil function by inhibitors of arachidonate metabolism reduces the extent of canine myocardial infarction.
Hoshida S; Kuzuya T; Nishida M; Kim Y; Kitabatake A; Kamada T; Tada M
Am J Cardiol; 1989 Mar; 63(10):24E-28E. PubMed ID: 2493731
[TBL] [Abstract][Full Text] [Related]
8. The effects of thromboxane A2 inhibitors (OKY-046 and ONO-3708) and leukotriene inhibitors (AA-861 and LY-171883) on CCl4-induced chronic liver injury in mice.
Shimazawa T; Nagai H; Koda A; Kasahara M
Prostaglandins Leukot Essent Fatty Acids; 1990 May; 40(1):67-71. PubMed ID: 2119043
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of selective inhibitor of thromboxane synthetase (OKY-046) and thromboxane antagonist (ONO-3708) on ischemia-induced mitochondrial dysfunction in canine heart.
Ito T; Ito Y; Torii T; Hieda N; Toki Y; Miyazaki Y; Hashimoto H; Ogawa K; Satake T
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():392-6. PubMed ID: 2959085
[No Abstract] [Full Text] [Related]
10. Effects of a thromboxane synthetase inhibitor, Y-20811, on infarct size, neutrophil accumulation, and arrhythmias after coronary artery occlusion and reperfusion in dogs.
Sato N; Endo T; Kiuchi K; Hayakawa H
J Cardiovasc Pharmacol; 1993 Mar; 21(3):353-61. PubMed ID: 7681494
[TBL] [Abstract][Full Text] [Related]
11. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of thromboxane A2 synthetase failed to limit myocardial infarct size in a rabbit ischemia-reperfusion model.
Tsuchida A; Miura T; Ogawa T; Iwamoto T; Shimamoto K; Iimura O
Jpn Circ J; 1991 Feb; 55(2):174-83. PubMed ID: 2020088
[TBL] [Abstract][Full Text] [Related]
13. Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
Grover GJ; Schumacher WA
J Pharmacol Exp Ther; 1989 Feb; 248(2):484-91. PubMed ID: 2521899
[TBL] [Abstract][Full Text] [Related]
14. The effect of the thromboxane A2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion.
Grover GJ; Schumacher WA; Simon M; Parham C
J Cardiovasc Pharmacol; 1988 Dec; 12(6):701-9. PubMed ID: 2467089
[TBL] [Abstract][Full Text] [Related]
15. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
Yao SK; Rosolowsky M; Anderson HV; Golino P; NcNatt JM; De Clerck F; Buja LM; Willerson JT
J Am Coll Cardiol; 1990 Sep; 16(3):705-13. PubMed ID: 2143767
[TBL] [Abstract][Full Text] [Related]
16. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
[TBL] [Abstract][Full Text] [Related]
17. Combined thromboxane A2 synthase inhibition and prostaglandin endoperoxide receptor antagonism limits myocardial infarct size after mechanical coronary occlusion and reperfusion at doses enhancing coronary thrombolysis by streptokinase.
Vandeplassche G; Hermans C; Somers Y; Van de Werf F; de Clerck F
J Am Coll Cardiol; 1993 Apr; 21(5):1269-79. PubMed ID: 8459087
[TBL] [Abstract][Full Text] [Related]
18. The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin.
Grover GJ; Parham CS; Schumacher WA
Basic Res Cardiol; 1991; 86(2):99-106. PubMed ID: 1831610
[TBL] [Abstract][Full Text] [Related]
19. Protective action of a thromboxane synthetase inhibitor in preventing extension of infarct size in acute myocardial infarction.
Hock CE; Phillips GR; Lefer AM
Prostaglandins Leukot Med; 1985 Mar; 17(3):339-46. PubMed ID: 3857643
[TBL] [Abstract][Full Text] [Related]
20. Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on blood vessels.
Kondo K; Seo R; Omawari N; Imawaka H; Wakitani K; Kira H; Okegawa T; Kawasaki A
Eur J Pharmacol; 1989 Sep; 168(2):193-200. PubMed ID: 2606148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
